Food & Drug Administration | eHealth News | Page 62

Natpara (parathyroid hormone) has been approved by the U.S. Food and Drug Administration to control hypocalcemia among people with hypoparathyroidism.

Natpara OK’d to Treat Low Blood Calcium in Hypoparathyroidism

HealthDay.com - Jan 26, 2015 0

Medication recommended for use in patients for whom the potential benefits outweigh potential risk

The U.S. Food and Drug Administration has approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.

FDA Approves New Drug to Treat Plaque Psoriasis

HealthDay.com - Jan 21, 2015 0

Cosentyx hinders protein that spurs skin inflammation

A new electrical stimulation device designed to control obesity by targeting the nerve pathways between the brain and stomach that regulate hunger and fullness has been approved by the U.S. Food and Drug Administration.

FDA: Stimulation Device Approved to Treat Obesity

HealthDay.com - Jan 14, 2015 0

Targets vagus nerve which regulates hunger

1...60 6162Page 62 of 62

Archives